Navigation Links
Shire Acquires US Rights to Resolor® (prucalopride)
Date:1/10/2012

PHILADELPHIA, January 10, 2012 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor® (prucalopride) in the United States (US) in an agreement  with Janssen Pharmaceutica N.V.  Terms of the agreement have not been disclosed.

Resolor, a prokinetic, is part of Shire's gastrointestinal (GI) portfolio in Europe and is approved for use in 33 countries for the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. Resolor is currently available in Germany, Ireland, Belgium, France, Greece and the United Kingdom, and will be commercially available in Italy in mid-January 2012. Additional launches throughout Europe are planned for 2012.

"We are excited about the opportunity to develop Resolor in the US and we look forward to working with the FDA and the GI physician community to define the path forward for registration of the medicine as a treatment for chronic constipation in the US," said Roger Adsett, Senior Vice President of Shire's global GI business.

Resolor was developed for the European market by the Belgian-based pharmaceutical company Movetis, which acquired the European rights to Resolor from Janssen Pharmaceutica N.V. Shire acquired Movetis in 2010.

Under the terms of the agreement, the US rights to the Resolor trademark will be transferred to Shire.

About Resolor (prucalopride)

Resolor is a 5-HT4 receptor agonist. 5-HT4 receptors are mainly found in the gut wall and are involved in the stimulation of high-amplitude contractions and coordination of bowel motility.

Resolor is indicated in the European Economic Area for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. &#
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Shire Provides Update on ProAmatine® (midodrine HCl)
2. National Pharmaceutical Council Welcomes Shire as Its Newest Member
3. Shire plc: Board Changes
4. Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
5. Shire plc : Second Quarter 2011 Results Date Notification - July 28, 2011
6. Shire Files Lawsuits Against Sandoz and Amneal for Infringement of VYVANSE® (lisdexamfetamine dimesylate) Patents
7. United Lincolnshire Hospitals NHS Trust Selects Jayex QI Interactive Patient Survey and Information Management Kiosk
8. Shire Completes Acquisition of Advanced BioHealing, Inc.
9. European Authorities Approve New Manufacturing Facility for Shires REPLAGAL® (agalsidase alfa)
10. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
11. Shire Recognized by ISPE Facility of the Year Awards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... 27, 2015 According to a ... Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), ... (AF, VT, WPW) - Global Forecasts to 2019 ", published ... reach around ~$4.73 Billion by 2019 with a CAGR ... 2019. Browse   90   ma ...
(Date:3/27/2015)... MARLBOROUGH, Mass. , March 27, 2015 ... ) and privately-held MirImmune LLC, today announced ... license agreement to RXi,s novel and proprietary ... cell-based cancer immunotherapies. The collaboration has the ... and patient friendly cancer treatments that could ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... , NEW YORK, Dec. 2 ... available in its catalogue: , Electrodes for Medical ... http://www.reportlinker.com/p0164320/Electrodes-for-Medical-Devices---A-Global-Market-Perspective.html , Electrodes in electronic devices detect electrical ... created by chemical reactions. Medical application areas include blood ...
... , PALO ALTO, Calif., Dec. 2 ... 2009, Varian, Inc. filed with the U.S. Securities and Exchange Commission ... October 2, 2009. This Annual Report may be accessed through ... "SEC Filings," and then on "10-K" in the table shown. ...
Cached Medicine Technology:Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 2Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 3Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 4Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 5Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 6Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 7
(Date:3/27/2015)... According to Health Day , on ... Abstinence Syndrome (NAS) are causing alarm for Florida officials. ... process for a month of their lives- and can ... vomiting. The condition is precipitated by drug use during ... (and employing medically assisted drug treatment) will also inflict ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global ... the SM1120 MEMS based ultra-miniature pressure sensor designed especially ... at only 220um x 75um provides ample space for ... With industry leading in vivo drift performance of ... broad operating pressure range from 0 to 1,100 mmHg ...
(Date:3/27/2015)... OR (PRWEB) March 27, 2015 California’s ... winter blizzards in Boston and the United States Northeast, ... patterns. Earth warming global atmosphere is creating changes in ... PhD, historical climatologist and former NASA researcher, speaking on ... The result is not only a warmer and dryer ...
(Date:3/27/2015)... 2015 Operatic contenders and their avid ... April 17th. The universally acclaimed baritone Sherrill Milnes will ... Opera Idol at The Merion in Evanston. The event ... drawn aspiring opera singers from around the country. “This ... the finest young talent in the country,” said Margaret ...
(Date:3/27/2015)... To address their number one lawn care question ... filming this video to explain the complicated dynamics between the ... often expected to thrive in, be it in dense building ... survive. Anytime a sun-loving plant is put in the shade ... homeowners try to amend this issue by applying large quantities ...
Breaking Medicine News(10 mins):Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:Opera Idol Competition At The Merion In Evanston 2Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... treatment could prevent several bone problems, , TUESDAY, Oct. 27 ... treatment with large doses of vitamin D2 can eliminate vitamin ... bay for up to six years. , The dosage ... was large but did not appear to be toxic, according ...
... ... vast reach across the U.S. healthcare industry with Susan G. Komen,s mission to cure ... ... with Susan G. Komen for the Cure®, the world,s largest breast cancer advocacy organization. ...
... Robert A. Douglas, 1st Vice President Senior Consultant Sales, ... Career Division national sales growth, Expansion of new RJR sales ... management experience and over 6 years of sales training experience ... in the development and implementation of several new divisions to ...
... Vestara, ... has been awarded a MedAssets supplier contract. MedAssets serves more than 1,700 hospitals and ... ... provider of the industry,s only automated pharmaceutical waste management solution, announced today that it ...
... , ... Homonculus Press, Mexico City, announces the publication of The American ... revealed two sets of parties of interest: A complaint against the first ... 24 Feb 2006 at the Lumpini Police Station against Bumrungrad International Hospital ...
... ... ... -- Morehead, the human capital research firm, will host a webinar titled "A Two-Pronged Strategy ... 17, 2009 at 1:00 p.m. EST. , , ,In this webinar, David Rowlee, Ph.D., ...
Cached Medicine News:Health News:Short-Term, High-Dose Vitamin D2 May Ease Deficiency 2Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 2Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 3Health News:Susan G. Komen for the Cure Partners with Healthcare IT Leader Emdeon for Innovative Breast Health Awareness Campaigns 4Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 2Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 3Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 4Health News:Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution 2Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 2Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 3Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 4Health News:The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg 5Health News:Morehead Presents Webinar on 'A Two-Pronged Strategy to Reduce Nurse Turnover' 2
... Optima MAX has the highest g-force ever. ... more than force. Optima MAX combines maximum ... achieve benchtop performance that's worlds apart from ... superior design, and enhanced efficiency, Optima takes ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
... chemistry system brings versatility in a ... laboratory. A model of innovation and ... system features state-of-the-art Dimension technology, specifically ... in a flexible, affordable, easy-to-use system ...
... Dimension clinical chemistry integrated systems combine the ... cartridge, the power of the Multiply and ... the heterogeneous module to meet the challenges ... broad test menus, the systems can meet ...
Medicine Products: